WESTBURY, N.Y., Nov. 20, 2012 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTCQB: VASO) today reported its operating results for the three- and nine-month periods ended September 30, 2012. “We reported another strong quarter of sales for our equipment segment in the third quarter.  However, changes to certain sales commission milestones for 2012 compared to 2011 have resulted...
Read More

WESTBURY, N.Y., Nov. 15, 2012 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTCQB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology including EECP® systems, the gold standard of ECP therapy, announced today that it was named to Deloitte’s Technology Fast 500™, a ranking of the fastest growing...
Read More

WESTBURY, N.Y., Oct. 31, 2012 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTCQB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology as well as in the domestic sale of diagnostic imaging products, announced today that it has retained KCSA Strategic Communications (KCSA), a leading New York-based communications...
Read More

WESTBURY, N.Y.–(BUSINESS WIRE)–Vasomedical, Inc. (“Vasomedical”) (OTCQB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products, today announced its engagement of a full service broker dealer to sponsor Vasomedical’s stock for quotation on the OTC Bulletin Board (“OTCBB”). The OTCBB...
Read More

WESTBURY, N.Y.–(BUSINESS WIRE)–Vasomedical, Inc. (“Vasomedical”) (OTCQB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products, today reported its operating results for the three and six months ended June 30, 2012. The Company reported an increase in revenue of $2.52...
Read More